col0,col1,col2,col3
cyclophosphamide,260.02482,systemic lupus erythematosus,alkylating agent
doxorubicin hydrochloride,579.151,benign mesothelioma,nucleic acid inhibitor
ganciclovir,255.097,neuroretinitis,nucleic acid inhibitor
doxorubicin hydrochloride,579.151,gastrointestinal system cancer,nucleic acid inhibitor
